Finding #3: The inhibition of pyruvate transport into mitochondria leads to an intracellular increase of aspartate, which is sufficient to trigger NSPC activation.
Finding #2: The import of pyruvate into mitochondria is necessary to maintain the quiescence of NSPCs. Deletion or inhibition of MPC in quiescent NSPCs triggers their activation.
Finding #1: Quiescent neural stem/progenitor cells (NSPCs) have an active mitochondrial metabolism and express high levels of mitochondrial pyruvate carrier (MPC).
@Novartis announced their T-Charge platform preserves #Tcell#stemness : the ability to self-renew and mature, resulting in a product containing greater proliferative potential and fewer exhausted T cells. #CARTcell#cancer#immunotherapy#celltherapy https://t.co/kiD73BqDQz
CHF 1.5 million for powering up T cells to fight cancer: @UNIGE_en spin-off MPC Therapeutics raises seed round to advance its program into the clinic by 2024. Kudos to biotech entrepreneurs Raphaël Martinou and Jean-Claude Martinou!
https://t.co/uI8t30YbEt
#VentureKick#Biotech
The mitochondrial pyruvate carrier (MPC) was discovered just 10 years ago but it is going to become a major player in health and disease. https://t.co/f7SbimZyOB
https://t.co/HFabKv2Xmq
Very excited to share our study on bioRxiv on how mitochondrial pyruvate metabolism regulates quiescent adult neural stem cells. #stemcells#mitochondria#metabolism. Great collaboration with @JCMartinou. Huge congrats to @PhDPetrelli @Val_N_Tina01!!
A very interesting and exaustive review (2018) about multifaced contribution of mitochondria to cellular metabolism by @JessicaSpinel16
https://t.co/VFRyyGl3fe